
Veteran investor Mukul Aggarwal has bought 2,35,000 shares in a pharma company. The name of the company is- Kilich Drugs India Limited. It is a smallcap stock.
Mukul Mahavir Aggarwal’s name is present in the latest shareholding pattern. He bought 1.34% stake in the company during the July-September 2025 quarter.
Promoters hold 63.77% stake in Kilitch Drugs India. The market cap of the company is around ₹650 crore. The face value of the share is ₹10.
Shares of Kilitch Drugs India closed at ₹370 on BSE on Friday, October 24. It has fallen 13% in 3 months. The 52-week high is ₹490 and low is ₹265.60.
The company’s standalone revenue in the June 2025 quarter stood at ₹34.12 crore. Meanwhile, the net profit stood at ₹4.79 crore. Standalone revenue in FY25 was ₹181.59 crore and net profit was ₹31.16 crore.
Kilich Drugs India is starting a greenfield project in Pen, Maharashtra with an investment of ₹160 crore. The first phase is almost completed.